BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 9113986)

  • 1. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.
    Forman BM; Chen J; Evans RM
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4312-7. PubMed ID: 9113986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma.
    Kliewer SA; Sundseth SS; Jones SA; Brown PJ; Wisely GB; Koble CS; Devchand P; Wahli W; Willson TM; Lenhard JM; Lehmann JM
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4318-23. PubMed ID: 9113987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.
    Krey G; Braissant O; L'Horset F; Kalkhoven E; Perroud M; Parker MG; Wahli W
    Mol Endocrinol; 1997 Jun; 11(6):779-91. PubMed ID: 9171241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acids, eicosanoids, and hypolipidemic agents regulate gene expression through direct binding to peroxisome proliferator-activated receptors.
    Wahli W; Devchand PR; IJpenberg A; Desvergne B
    Adv Exp Med Biol; 1999; 447():199-209. PubMed ID: 10086196
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha.
    Murakami K; Ide T; Suzuki M; Mochizuki T; Kadowaki T
    Biochem Biophys Res Commun; 1999 Jul; 260(3):609-13. PubMed ID: 10403814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand selectivity of the peroxisome proliferator-activated receptor alpha.
    Lin Q; Ruuska SE; Shaw NS; Dong D; Noy N
    Biochemistry; 1999 Jan; 38(1):185-90. PubMed ID: 9890897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARs: nuclear receptors for fatty acids, eicosanoids, and xenobiotics.
    Devchand PR; Ijpenberg A; Devesvergne B; Wahli W
    Adv Exp Med Biol; 1999; 469():231-6. PubMed ID: 10667335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus.
    Wolfrum C; Borrmann CM; Borchers T; Spener F
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2323-8. PubMed ID: 11226238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptors and the regulation of mammalian lipid metabolism.
    Smith SA
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):1086-90. PubMed ID: 12440979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation.
    Bishop-Bailey D; Wray J
    Prostaglandins Other Lipid Mediat; 2003 Apr; 71(1-2):1-22. PubMed ID: 12749590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine.
    Poirier H; Niot I; Monnot MC; Braissant O; Meunier-Durmort C; Costet P; Pineau T; Wahli W; Willson TM; Besnard P
    Biochem J; 2001 Apr; 355(Pt 2):481-8. PubMed ID: 11284737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding Peroxisome Proliferator-Activated Receptors: From the Structure to the Regulatory Actions on Metabolism.
    Lamas Bervejillo M; Ferreira AM
    Adv Exp Med Biol; 2019; 1127():39-57. PubMed ID: 31140170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nuclear receptor PPARgamma - bigger than fat.
    Kliewer SA; Willson TM
    Curr Opin Genet Dev; 1998 Oct; 8(5):576-81. PubMed ID: 9794815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor agonists.
    Willson TM; Wahli W
    Curr Opin Chem Biol; 1997 Aug; 1(2):235-41. PubMed ID: 9667857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic significance of peroxisome proliferator-activated receptor modulators in diabetes.
    Ram VJ
    Drugs Today (Barc); 2003 Aug; 39(8):609-32. PubMed ID: 14566384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N; Duez H; Fruchart JC; Staels B
    Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-chain polyunsaturated fatty acids regulation of PPARs, signaling: Relationship to tissue development and aging.
    Echeverría F; Ortiz M; Valenzuela R; Videla LA
    Prostaglandins Leukot Essent Fatty Acids; 2016 Nov; 114():28-34. PubMed ID: 27926461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acids bind directly to and activate peroxisome proliferator-activated receptors alpha and gamma.
    Wolf G
    Nutr Rev; 1998 Feb; 56(2 Pt 1):61-3. PubMed ID: 9529901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
    Chinetti G; Fruchart JC; Staels B
    Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of peroxisome proliferator-activated receptors by eicosanoids.
    Yu K; Bayona W; Kallen CB; Harding HP; Ravera CP; McMahon G; Brown M; Lazar MA
    J Biol Chem; 1995 Oct; 270(41):23975-83. PubMed ID: 7592593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.